$50 Million Investment to Finance Growth in Chindex's Healthcare Network in
BETHESDA, Md., Nov. 7 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX) a leading independent American provider of Western healthcare services and products in the People's Republic of China, today announced that it has agreed to an investment by JPMorgan's Principal Investment Management group. The investment will consist of $10 million of the Company's common stock and $40 million of zero coupon convertible notes for aggregate proceeds of $50 million. The purchase price for the common stock and the conversion price of the notes will be $27.84 per share. The net proceeds from the investment will be used primarily toward the development of new hospitals in P.R. China. The closing of the investment is subject to certain conditions, including compliance with Nasdaq listing requirements.
About Chindex International, Inc.
Chindex is an American healthcare company that provides healthcare
services and supplies medical capital equipment, instrumentation and
products to the Chinese marketplace, including Hong Kong. It provides
healthcare services through the operations of its United Family Hospitals
and Clinics, a network of private primary care hospitals and affiliated
ambulatory clinics in China. The Company's hospital network currently
operates in the Beijing and Shanghai metropolitan areas. The Company sells
medical products manufactured by various major multinational companies,
including Siemens AG, which is the Company's exclusive distribution partner
for the sale and servicing of color doppler ultrasound systems. It also
arranges financing packages for the supply of medic
|SOURCE Chindex International, Inc.|
Copyright©2007 PR Newswire.
All rights reserved